跳至主要内容
临床试验/ISRCTN61891868
ISRCTN61891868已完成不适用

Comparison of two alternative combinations of nucleosides in HIV-1 infected patients with viral suppression on 3TC. Randomized, multicentre open trial.

Sponsor not yet defined (Spain)0 个研究点目标入组 300 人开始时间: 2006年1月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Male and female
  • 2. HIV-1-infected
  • 3. Age 18 and above
  • 4. On stable highly active antiretroviral therapy (HAART), including lamivudine (3TC) for at least last 3 months
  • 5. Plasma viral load <200 copies/ml for at least 4 months
  • 6. Written informed consent

排除标准

  • 1. Pregnancy, breastfeeding or intent to become pregnant during the study period
  • 2. Active opportunistic infection requiring treatment by parenteral route
  • 3. Creatinine (serum) >2 mg/dl
  • 4. Current treatment with potentially nephrotoxic agents: aminoglicosides, amfotericin B, cidofovir, cisplatin, foscarnet, pentamidine IV
  • 5. Treatment with adefovir, probenecid, interleukin-2, systemic steroids or investigational agents
  • 6. Systemic antineoplastic chemotherapy
  • 7. Any contraindication for study drugs
  • 8. Prior failure on combinations including abacavir or tenofovir or with mutations of resistance to these drugs

研究者

发起方
Sponsor not yet defined (Spain)

相似试验

Comparison of two alternative combinations of... | 临床试验